Susquehanna International Group, LLP Biomea Fusion, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 51,445 shares of BMEA stock, worth $92,601. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,445
Previous 20,186
154.85%
Holding current value
$92,601
Previous $78,000
39.74%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BMEA
# of Institutions
109Shares Held
16.1MCall Options Held
229KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$6.43 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$4.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.48 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.44 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA626KShares$1.13 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $52.7M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...